Ivermectin

Fluoxetine not effective for COVID-19 patients

by

Evidence shows weak antiviral activity and no improvement in symptom outcomes. Study: Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV). Image Credit: luchschenF/Shutterstock.com In a recent study published in eClinicalMedicine, researchers characterized the antiviral activity of a selective serotonin reuptake inhibitor (SSRI), fluoxetine, in early coronavirus disease 2019 (COVID-19). … Read more

Innovative tablet combination shows promise in fighting Trichuris trichiura and other helminths

by

A new tablet combining albendazole and ivermectin is safe and more effective than albendazole alone in treating Trichuris trichiura and other soil-transmitted helminths (STH), according to a clinical trial conducted by the STOP consortium and led by the Barcelona Institute of Global Health (ISGlobal), a centre supported by “la Caixa” Foundation. The findings, published in The Lancet Infectious Diseases, open … Read more